ProMIS Neurosciences shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.
ProMIS Neurosciences shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.